- Raw materials
- Hormonal Agents
- Trenbolone
Filters
Custom request?
Type
Production region
Qualifications
Country of origin
Trenbolone API Manufacturers & Suppliers
1 verified results
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Commercial-scale Suppliers
Employees: 550+
All certificates
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Trenbolone | CAS No: 10161-33-8 | GMP-certified suppliers
A medication that supports muscle growth and appetite enhancement in livestock, primarily used in veterinary medicine for improved feed efficiency and weight gain.
Therapeutic categories
Product Snapshot
- Trenbolone is an injectable anabolic steroid formulation primarily used in veterinary applications
- Its main therapeutic use is to promote muscle growth and improve feed efficiency in livestock
- Trenbolone is approved for veterinary use but does not have FDA approval for human medical applications
Clinical Overview
Pharmacologically, trenbolone acts as a potent anabolic agent, facilitating enhanced protein synthesis and nitrogen retention in muscle tissue, thus supporting muscle hypertrophy and increased body mass. In practice, trenbolone is administered via esterified prodrugs such as trenbolone acetate, trenbolone enanthate, or trenbolone cyclohexylmethylcarbonate. These ester conjugates improve the pharmacokinetic profile by extending the effective half-life through slow hydrolysis by plasma lipases, releasing the active parent compound into circulation.
Absorption and distribution of trenbolone rely on intramuscular depot injection of its ester forms, followed by enzymatic cleavage to free trenbolone. While comprehensive ADME data specific to trenbolone are limited in the public domain, its lipophilicity and ester prodrug design ensure sustained systemic exposure. Metabolism primarily involves hepatic pathways, with excretion routes consistent with steroidal agents.
Safety and toxicity considerations are pertinent due to trenbolone’s powerful androgenic and anabolic effects. Adverse effects in non-target species and potential environmental impacts warrant controlled use. No human therapeutic approvals exist, underscoring the need for caution outside veterinary contexts.
From an API procurement perspective, quality control should ensure the identity, purity, and stability of trenbolone esters, with adherence to veterinary pharmaceutical standards. Suppliers should provide detailed certificates of analysis and comply with applicable regulatory frameworks to ensure safe and consistent manufacture.
Identification & chemistry
| Generic name | Trenbolone |
|---|---|
| Molecule type | Small molecule |
| CAS | 10161-33-8 |
| UNII | P53R4420TR |
| DrugBank ID | DB11551 |
Formulation & handling
- Trenbolone is a small molecule steroid with low water solubility, requiring formulation strategies to enhance bioavailability for oral or injectable use. Its lipophilicity (LogP 2.25) suggests moderate membrane permeability but potential challenges in aqueous formulations. Stability considerations should include protection from hydrolysis and oxidation typical of steroid structures.
Regulatory status
Trenbolone is a type of Hormonal Agents
Hormonal agents are a prominent category of pharmaceutical active pharmaceutical ingredients (APIs) widely used in the medical field. These substances play a crucial role in regulating and modulating hormonal functions within the body. Hormonal agents are designed to mimic or manipulate the effects of naturally occurring hormones, allowing healthcare professionals to treat various endocrine disorders and hormonal imbalances.
Hormonal agents are commonly employed in the treatment of conditions such as hypothyroidism, hyperthyroidism, diabetes, and hormonal cancers. These APIs work by interacting with specific hormone receptors, either by stimulating or inhibiting their activity, to restore the balance of hormones in the body. They can be administered orally, intravenously, or through other routes depending on the specific medication and patient needs.
Pharmaceutical companies employ rigorous manufacturing processes and quality control measures to ensure the purity, potency, and safety of hormonal agent APIs. These APIs are synthesized using chemical or biotechnological methods, often starting from natural hormone sources or through recombinant DNA technology. Stringent regulatory guidelines are in place to guarantee the efficacy and safety of hormonal agent APIs, ensuring that patients receive high-quality medications.
As the demand for hormone-related therapies continues to grow, ongoing research and development efforts focus on enhancing the effectiveness and reducing the side effects of hormonal agent APIs. This includes the exploration of novel delivery systems, advanced formulations, and targeted drug delivery methods. By continuously advancing our understanding and capabilities in hormonal agents, the medical community can improve patient outcomes and quality of life for individuals with hormonal disorders.
Trenbolone API manufacturers & distributors
Compare qualified Trenbolone API suppliers worldwide. We currently have 1 companies offering Trenbolone API, with manufacturing taking place in 1 different countries. Use the table below to review supplier type, countries of origin, certifications, product portfolio and GMP audit availability.
| Supplier | Type | Country | Product origin | Certifications | Portfolio |
|---|---|---|---|---|---|
| Minakem | Producer | France | France | CoA, FDA, GMP, USDMF | 31 products |
When sending a request, specify which Trenbolone API quality you need: for example EP (Ph. Eur.), USP, JP, BP, or another pharmacopoeial standard, as well as the required grade (base, salt, micronised, specific purity, etc.).
Use the list above to find high-quality Trenbolone API suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our help page to learn more about sourcing APIs via Pharmaoffer.
